NZ331509A - Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents - Google Patents

Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents

Info

Publication number
NZ331509A
NZ331509A NZ331509A NZ33150997A NZ331509A NZ 331509 A NZ331509 A NZ 331509A NZ 331509 A NZ331509 A NZ 331509A NZ 33150997 A NZ33150997 A NZ 33150997A NZ 331509 A NZ331509 A NZ 331509A
Authority
NZ
New Zealand
Prior art keywords
contrast agents
stabilised
microbubble
gas
microbubbles
Prior art date
Application number
NZ331509A
Other languages
English (en)
Inventor
Harald Dugstad
Jo Klaveness
Pal Rongved
Roald Skurtveit
Jorun Braenden
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603466.5A external-priority patent/GB9603466D0/en
Priority claimed from GBGB9611894.8A external-priority patent/GB9611894D0/en
Priority claimed from GBGB9625663.1A external-priority patent/GB9625663D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NZ331509A publication Critical patent/NZ331509A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NZ331509A 1996-02-19 1997-02-19 Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents NZ331509A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9625663.1A GB9625663D0 (en) 1996-12-11 1996-12-11 Improvements in or relating to contrast agents
PCT/GB1997/000459 WO1997029783A1 (en) 1996-02-19 1997-02-19 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
NZ331509A true NZ331509A (en) 2000-04-28

Family

ID=27268137

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ331509A NZ331509A (en) 1996-02-19 1997-02-19 Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents

Country Status (24)

Country Link
US (4) US6221337B1 (cg-RX-API-DMAC10.html)
EP (2) EP0881915B1 (cg-RX-API-DMAC10.html)
JP (1) JP4418033B2 (cg-RX-API-DMAC10.html)
KR (1) KR100500334B1 (cg-RX-API-DMAC10.html)
CN (1) CN1278740C (cg-RX-API-DMAC10.html)
AP (1) AP890A (cg-RX-API-DMAC10.html)
AT (1) ATE238072T1 (cg-RX-API-DMAC10.html)
AU (1) AU726503B2 (cg-RX-API-DMAC10.html)
BG (1) BG102758A (cg-RX-API-DMAC10.html)
CA (1) CA2246779C (cg-RX-API-DMAC10.html)
CZ (1) CZ293986B6 (cg-RX-API-DMAC10.html)
DE (1) DE69721235T2 (cg-RX-API-DMAC10.html)
EA (1) EA001135B1 (cg-RX-API-DMAC10.html)
EE (1) EE04224B1 (cg-RX-API-DMAC10.html)
ES (1) ES2197986T3 (cg-RX-API-DMAC10.html)
HU (1) HU229090B1 (cg-RX-API-DMAC10.html)
IL (1) IL125748A (cg-RX-API-DMAC10.html)
NZ (1) NZ331509A (cg-RX-API-DMAC10.html)
OA (1) OA10839A (cg-RX-API-DMAC10.html)
PL (1) PL328406A1 (cg-RX-API-DMAC10.html)
PT (1) PT881915E (cg-RX-API-DMAC10.html)
SK (1) SK284200B6 (cg-RX-API-DMAC10.html)
TR (1) TR199801613T2 (cg-RX-API-DMAC10.html)
WO (1) WO1997029783A1 (cg-RX-API-DMAC10.html)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918546B1 (en) * 1996-08-02 2008-10-15 GE Healthcare AS Improvements in or relating to contrast agents
AU784367B2 (en) * 1996-08-02 2006-03-16 Ge Healthcare As Improvements in or relating to contrast agents
JP4317270B2 (ja) * 1997-08-12 2009-08-19 ブラッコ・リサーチ・ソシエテ・アノニム 投与性組成物および磁気共鳴画像法
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717588D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9726773D0 (en) 1997-12-18 1998-02-18 Nycomed Imaging As Improvements in or relating to ultrasonagraphy
AU3719799A (en) * 1998-04-28 1999-11-16 Nycomed Imaging As Improvements in or relating to separation processes
GB9813568D0 (en) 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6514209B1 (en) 1999-06-07 2003-02-04 Drexel University Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
US20030103960A1 (en) * 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
KR100373712B1 (ko) * 2000-12-23 2003-02-25 사회복지법인삼성생명공익재단(삼성서울병원) 초음파 조영제 및 그의 제조방법
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
EP1387637B1 (en) 2001-04-06 2007-10-31 Bracco Research S.A. Apparatus for measuring local physical parameters in a fluid filled cavity
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
SI2301587T1 (sl) 2002-03-01 2014-11-28 Dyax Corp. KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
KR20050072496A (ko) 2002-11-29 2005-07-11 아머샴 헬스 에이에스 초음파 촬영 방법
WO2004069284A2 (en) * 2003-02-04 2004-08-19 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
AU2004217894B2 (en) 2003-03-03 2010-07-15 Bracco International B.V. Peptides that specifically bind HGF receptor (cMet) and uses thereof
WO2005002546A1 (en) * 2003-06-27 2005-01-13 Smithkline Beecham Corporation Stabilized topotecan liposomal composition and methods
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
NO20035401D0 (no) * 2003-12-04 2003-12-04 Amersham Health As Metode
CN1897978B (zh) * 2003-12-22 2011-11-23 博莱科瑞士股份有限公司 具有用于反差成像的活性组分的充气微囊组件
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
EP1784228B1 (en) 2004-08-18 2016-10-05 Bracco Suisse SA Gas-filled microvesicles composition for contrast imaging
WO2006044996A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for automated boundary detection of body structures
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
EP1937151A4 (en) * 2005-09-19 2011-07-06 Univ Columbia Systems and methods for opening of the blood-brain barrier of a subject using ultrasound
CA2631716C (en) 2005-12-09 2013-11-26 Bracco International B.V. Targeting vector-phospholipid conjugates
EP1797919A1 (en) 2005-12-16 2007-06-20 Bracco Research S.A. Liquid transfer device for medical dispensing containers
AR059193A1 (es) 2006-01-31 2008-03-12 Bayer Schering Pharma Ag Modulacion de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
EP2076179B1 (en) 2006-08-01 2018-07-04 Stichting voor de Technische Wetenschappen Pulse inversion sequences for nonlinear imaging
WO2008027520A2 (en) * 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Systems and methods for composite elastography and wave imaging
DE602007006968D1 (de) 2006-09-05 2010-07-15 Bracco Research Sa Gasgefüllte mikrovesikel mit polymer-modifizierten lipiden
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
WO2011035312A1 (en) 2009-09-21 2011-03-24 The Trustees Of Culumbia University In The City Of New York Systems and methods for opening of a tissue barrier
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2010014977A1 (en) * 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
WO2010030779A1 (en) * 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Isolation of microbubbles of selected size range from polydisperse microbubbles
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
EP2477550A4 (en) * 2009-09-15 2013-12-04 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR MICROBUBBLES
US9700640B2 (en) * 2009-09-21 2017-07-11 Drexel University Stabilized ultrasound contrast agent
US8834846B2 (en) 2010-05-06 2014-09-16 Bruker Biospin Corporation Fluorescent NIRF activatable probes for disease detection
US9265483B2 (en) 2010-08-06 2016-02-23 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
EP2844362B1 (en) 2012-04-30 2020-02-26 Ge Healthcare As Method for filling a container with a foamable composition
KR102139393B1 (ko) 2012-06-26 2020-07-29 지이 헬스케어 에이에스 기체 미세기포를 포함하는 조성물의 제조
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
US10010630B2 (en) 2012-12-21 2018-07-03 Bracco Suisse S.A. Gas-filled microvesicles
WO2014142926A1 (en) 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
EP2983687B1 (en) 2013-03-15 2019-09-04 The Regents of The University of California Peptides having reduced toxicity that stimulate cholesterol efflux
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
ES2726924T3 (es) 2014-12-18 2019-10-10 Bracco Suisse Sa Formulación de microvesículas dirigidas rellenas de gas
EP3308779B1 (en) * 2015-06-10 2019-08-07 Teikyo University Theranostic bubble preparation (tb), and method for using same
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (cg-RX-API-DMAC10.html) * 1990-04-02 1993-05-01 Sint Sa
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9511488D0 (en) * 1995-06-07 1995-08-02 Nycomed Imaging As Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator

Also Published As

Publication number Publication date
EP0881915B1 (en) 2003-04-23
PT881915E (pt) 2003-09-30
AP9801319A0 (en) 1998-09-30
US6221337B1 (en) 2001-04-24
JP4418033B2 (ja) 2010-02-17
US20030202942A1 (en) 2003-10-30
ES2197986T3 (es) 2004-01-16
EP1331013A3 (en) 2004-03-24
HUP9900813A3 (en) 1999-11-29
TR199801613T2 (xx) 1998-11-23
EP0881915A1 (en) 1998-12-09
BG102758A (en) 1999-09-30
OA10839A (en) 2001-08-13
DE69721235D1 (de) 2003-05-28
PL328406A1 (en) 1999-01-18
EE04224B1 (et) 2004-02-16
IL125748A (en) 2002-05-23
EA001135B1 (ru) 2000-10-30
EP1331013A2 (en) 2003-07-30
SK112698A3 (en) 1999-04-13
AU1884797A (en) 1997-09-02
WO1997029783A1 (en) 1997-08-21
ATE238072T1 (de) 2003-05-15
CA2246779C (en) 2008-04-29
US20010010811A1 (en) 2001-08-02
IL125748A0 (en) 1999-04-11
CZ262598A3 (cs) 1999-05-12
DE69721235T2 (de) 2004-02-05
HK1014872A1 (en) 1999-10-08
EA199800745A1 (ru) 1999-02-25
AU726503B2 (en) 2000-11-09
SK284200B6 (sk) 2004-10-05
KR100500334B1 (ko) 2005-09-09
CN1278740C (zh) 2006-10-11
HUP9900813A2 (hu) 1999-07-28
JP2000511510A (ja) 2000-09-05
US20050201942A1 (en) 2005-09-15
CZ293986B6 (cs) 2004-09-15
AP890A (en) 2000-11-13
EE9800249A (et) 1999-02-15
HU229090B1 (en) 2013-07-29
KR19990082669A (ko) 1999-11-25
CN1213972A (zh) 1999-04-14
CA2246779A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
NZ331509A (en) Aqueous dispersions of stabilised gas microbubbles and their use as contrast agents
CA1208133A (en) Pulverulent mixture of lipidic constituents and hydrop hobic constituents, methods for obtaining the same hyd rated lipidic lamellar phases and method for producing the same, pharmaceutical or cosmetic compositions com prising hydrated lipidic lamellar phases
DE69530939D1 (de) Schäumbare formulierung und schäum
IL124373A (en) Method of producing morphologically uniform microcapsules and microcapsules produced by this method
JPH0320214A (ja) 化粧品および製薬分野で用いることが出来る泡状物の調整方法とこの方法で得られる泡状物
DE60017406D1 (de) Verfahren zur herstellung von in lipid verkapselten therapeutischen wirkstoffen
WO2002049617A3 (en) Self forming, thermodynamically stable liposomes and their applications
ES2094688A1 (es) Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
ZA852168B (en) Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion
MY112798A (en) Oil-in-water emulsions
BG106689A (en) Method for the production of particles
EP1764091A3 (en) Improvements in or relating to amphoteric liposomes
CA2223417A1 (en) Method for the manufacture of minimal volume capsules containing biological material
WO1999040771A3 (en) Concurrent flow mixing for preparing compositions comprising gene therapy vectors
GR3018064T3 (en) Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof.
Ghannam et al. Interaction of type-I collagen with phospholipid monolayer
FR2790975B1 (fr) Milieux sous forme de dispersions complexes, leur procede de preparation et leurs utilisations
ZA946064B (en) Functional oxygenaceous preparation
ZA987480B (en) Process for preparing contrast agents.
TW376386B (en) Bioregulatory active substance, method for its production and use thereof
CA2138049A1 (en) Microemulsified hair treatment products and methods of making same
EP0955331A3 (en) Self-water dispersible particle made of biodegradable polyester and process for the preparation thereof
van Dalen et al. Preparation and characterization of liposomes with incorporated Neissería gonorrhoeae protein IB and amphiphilic adjuvants
FI77778C (fi) Kosmetiskt medel innehaollande en dubbelemulsion och foerfarande foer dess framstaellning.
Somasundaran et al. 6 Contribution of